|
|||||
|
|
What to expect after natalizumab cessation in a real‐life setting |
|
| Authors: | S. Salhofer‐Polanyi A. Baumgartner J. Kraus E. Maida M. Schmied F. Leutmezer The Austrian Tysabri Registry Group |
| Affiliation: | 1. Department of Neurology, Medical University of Vienna, , Vienna, Austria;2. Paracelsus Medical University, , Salzburg, Austria;3. Private Office, , Vienna, Austria |
| Abstract: | |
| Keywords: | discontinuation disease activity multiple sclerosis natalizumab rebound |